2019
DOI: 10.3390/cells8111366
|View full text |Cite
|
Sign up to set email alerts
|

ACVR1 Function in Health and Disease

Abstract: Activin A receptor type I (ACVR1) encodes for a bone morphogenetic protein type I receptor of the TGFβ receptor superfamily. It is involved in a wide variety of biological processes, including bone, heart, cartilage, nervous, and reproductive system development and regulation. Moreover, ACVR1 has been extensively studied for its causal role in fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder characterised by progressive heterotopic ossification. ACVR1 is linked to different pathologies, inc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
63
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(65 citation statements)
references
References 194 publications
(302 reference statements)
2
63
0
Order By: Relevance
“…Therefore, despite extensive molecular characterization, we cannot in general say how specific ligands will function in combinations, why these combinatorial effects vary with context, and what molecular features are necessary to generate the combinatorial and contextual behavior of BMP ligands. Addressing these questions would advance our understanding of the role of BMP signaling components in a variety of skeletal, respiratory, and brain diseases (Salazar, Gamer, and Rosen 2016; Valer et al 2019; Cunha and Pietras 2011) and aid the selection of therapeutic BMPs to selectively induce bone growth in orthopedics and oral surgery (Cicciù et al 2014; Carragee, Hurwitz, and Weiner 2011; Seeherman et al 2019). More generally, it could enable more precise control of cell fate decisions for therapeutic applications and provide insight into the overall logic of cell-cell communication systems.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, despite extensive molecular characterization, we cannot in general say how specific ligands will function in combinations, why these combinatorial effects vary with context, and what molecular features are necessary to generate the combinatorial and contextual behavior of BMP ligands. Addressing these questions would advance our understanding of the role of BMP signaling components in a variety of skeletal, respiratory, and brain diseases (Salazar, Gamer, and Rosen 2016; Valer et al 2019; Cunha and Pietras 2011) and aid the selection of therapeutic BMPs to selectively induce bone growth in orthopedics and oral surgery (Cicciù et al 2014; Carragee, Hurwitz, and Weiner 2011; Seeherman et al 2019). More generally, it could enable more precise control of cell fate decisions for therapeutic applications and provide insight into the overall logic of cell-cell communication systems.…”
Section: Introductionmentioning
confidence: 99%
“…Overexpression of ACVR1B , a key receptor of bone morphogenetic proteins (BMPs) and an important regulator of the BMP/Wnt signaling pathway and, therefore, for cancer stem cells, was associated with clinically aggressive and poor survival in hepatocellular carcinoma [ 33 ]. The implication of ACVR1B and BMP in cancer has exhibited a dual function according to different cancer cell types or different BMP ligands, promoting or preventing critical cancer hallmarks such as stemness, migration, or proliferation [ 34 ]. Protein expression of Caspase-3, either the cleaved fraction or total protein, was associated with poor prognosis in patients with moderately-differentiated carcinoma of the tongue [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…There are also rare, inherited forms of HO, such as fibrodysplasia ossificans progressiva (FOP) and progressive osseous heteroplasia (POH) [ 44 , 45 ]. FOP is autosomal-dominant disorder caused by up to 14 different mutations localised in the type I bone morphogenic protein (BMP) receptor, i.e., activin type 1 receptor (ACVR1; also called activin-like kinase 2, ALK2) gene [ 44 , 46 ]. However, a single mutation, i.e., arginine to histidine at position 206; R206H, is present in the majority of FOP patients [ 44 , 46 ].…”
Section: Heterotopic Ossification As a Clinical Issuementioning
confidence: 99%
“…FOP is autosomal-dominant disorder caused by up to 14 different mutations localised in the type I bone morphogenic protein (BMP) receptor, i.e., activin type 1 receptor (ACVR1; also called activin-like kinase 2, ALK2) gene [ 44 , 46 ]. However, a single mutation, i.e., arginine to histidine at position 206; R206H, is present in the majority of FOP patients [ 44 , 46 ]. The ossification of skeletal muscles in FOP occurs mostly in early childhood and is characterized by inflammation-like symptoms and episodical flareups [ 44 ].…”
Section: Heterotopic Ossification As a Clinical Issuementioning
confidence: 99%